Completed PHASE2 INTERVENTIONAL 1-arm NCT00278694

Oxaliplatin and 5-FU Based Preoperative Chemoradiation (LARC-RRP)

Sponsor: Oslo University Hospital

Interventions 5-FU Chemoradiation Neoadjuvant oxaliplatin Oxaliplatin Pelvic surgery Preoperative chemoradiation

Updated 5 times since 2017 Last updated: Sep 28, 2016 Started: Sep 30, 2005 Primary completion: Feb 29, 2016 Completion: Feb 29, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Rectal Cancer and is currently completed. Oslo University Hospital leads this study, which shows 5 recorded versions since 2005 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Sep 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Oslo University Hospital

Data source: Oslo University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Oslo, Norway